by Massachusetts Institute of Technology A trial participant undergoes an MRI scan at MIT. Credit: The Picower Institute for Learning and Memory at MIT Two early stage clinical studies testing the safety and efficacy of 40Hz sensory stimulation to treat Alzheimer’s disease have found that the potential therapy was well tolerated, produced no serious adverse...
